NL7909199A - Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. - Google Patents

Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. Download PDF

Info

Publication number
NL7909199A
NL7909199A NL7909199A NL7909199A NL7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A NL 7909199 A NL7909199 A NL 7909199A
Authority
NL
Netherlands
Prior art keywords
thiazolidine
carboxylic acid
pharmaceutically acceptable
acceptable salt
agent
Prior art date
Application number
NL7909199A
Other languages
English (en)
Dutch (nl)
Original Assignee
Gosalvez Mario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gosalvez Mario filed Critical Gosalvez Mario
Publication of NL7909199A publication Critical patent/NL7909199A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NL7909199A 1978-12-21 1979-12-20 Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan. NL7909199A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97172978 1978-12-21
US05/971,729 US4384001A (en) 1978-12-21 1978-12-21 Treatment of tumors with thiazolidine-4-carboxylic acid

Publications (1)

Publication Number Publication Date
NL7909199A true NL7909199A (nl) 1980-06-24

Family

ID=25518727

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7909199A NL7909199A (nl) 1978-12-21 1979-12-20 Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan.

Country Status (16)

Country Link
US (1) US4384001A (es)
JP (1) JPS55115822A (es)
AU (1) AU5390579A (es)
BE (1) BE880744A (es)
CA (1) CA1149284A (es)
DE (1) DE2951050A1 (es)
DK (1) DK542979A (es)
ES (1) ES8102108A1 (es)
FR (1) FR2444459A1 (es)
GB (1) GB2039736B (es)
IL (1) IL58948A0 (es)
IT (1) IT1193348B (es)
LU (1) LU82013A1 (es)
NL (1) NL7909199A (es)
SE (1) SE7910300L (es)
ZA (1) ZA796918B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS57128625A (en) * 1981-01-30 1982-08-10 Rikagaku Kenkyusho Carcinostatic
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
FR2547729B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide dl thiazolidine carboxylique
FR2547728B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide d thiazolidine carboxylique
JPS62501769A (ja) * 1984-12-18 1987-07-16 デイビツト　ラビン 細胞毒性アルデヒドとベニシラミンとの反応性成物を含有する抗腫瘍組成物及びその使用方法
JPH066578B2 (ja) * 1985-12-27 1994-01-26 三共株式会社 チアゾリジン誘導体
JPH01170063U (es) * 1988-05-11 1989-11-30
JPH0467539U (es) * 1990-10-18 1992-06-16
EP0494405B2 (en) * 1991-01-10 2000-04-19 Transcend Therapeutics, Inc. Use of L-2-oxo thiazolidine-4-carboxylate for the treatment of pulmonary diseases
ES2277787B1 (es) * 2006-01-02 2008-06-16 Universidad De Cadiz Empleo de tioprolina en tratamientos de reduccion de peso corporal.

Also Published As

Publication number Publication date
ES487052A0 (es) 1980-12-16
FR2444459A1 (fr) 1980-07-18
US4384001A (en) 1983-05-17
BE880744A (fr) 1980-06-19
CA1149284A (en) 1983-07-05
ZA796918B (en) 1980-11-26
SE7910300L (sv) 1980-06-22
ES8102108A1 (es) 1980-12-16
IL58948A0 (en) 1980-03-31
GB2039736A (en) 1980-08-20
JPS55115822A (en) 1980-09-06
DK542979A (da) 1980-06-22
IT7928170A0 (it) 1979-12-18
LU82013A1 (fr) 1981-02-03
JPS6328045B2 (es) 1988-06-07
IT1193348B (it) 1988-06-15
AU5390579A (en) 1980-06-26
GB2039736B (en) 1983-04-13
FR2444459B1 (es) 1983-04-01
DE2951050A1 (de) 1980-07-10

Similar Documents

Publication Publication Date Title
SK137996A3 (en) Cancer treatment and metastasis prevention
NL7909199A (nl) Farmaceutisch preparaat voor het behandelen van nieuw- vormingsziekten en werkwijzen voor het bereiden ervan.
US6407125B1 (en) Pharmacological agent and method of treatment
US20060074063A1 (en) Pharmacological agent and method of treatment
CN111346081B (zh) 包含正戊酸、吲哚丙酸和正丁酸钠的药物组合物的新用途
WO2002020486A2 (en) Picolinic acid derivatives for the prevention and treatment of cancer in animals
CN115463118A (zh) 和厚朴酚在制备治疗或预防毛细血管瘤的药物中的用途
JP2003522786A (ja) 薬理学的薬剤、及び治療の方法
AU709620B2 (en) New applications of lysozyme dimer
DE60032915T2 (de) Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen
KR20060061367A (ko) 디파이브로타이드를 단독으로 또는 다른 항암제들과조합하여 포함하는 항암제제
Taliaferro The Role of the Spleen and the Lymphoid-macrophage System in the Quinine Treatment of Gallinaceum Malaria: I. Acquired Immunity and Phagocytosis
JPS6379824A (ja) 制癌剤
WO2021023291A1 (zh) 原黄素在肺癌治疗中的应用
US6441009B1 (en) Agent and method of preventing and treating heavy metal exposure and toxicity
KR20060038387A (ko) 화학요법을 받고 있는 암 환자를 치료하는 방법
Boughattas et al. Modulation of cisplatin chronotoxicity related to reduced glutathione in mice
CN111514290A (zh) 一种葫芦素组合物及其用途
RU2680804C1 (ru) Стабильное средство лечения болезней суставов
CN113456643B (zh) 一种含普那布林的药物组合及其应用
NL8501840A (nl) Inhibitie van tumorontwikkeling.
RU2426531C1 (ru) Жидкая водная фармацевтическая композиция амброксола и фармацевтический препарат на ее основе, предназначенные для лечения заболеваний дыхательных путей с образованием вязкой мокроты (варианты)
RU2282437C1 (ru) Средство для лечения болезней суставов
RU2681546C1 (ru) Способ экстренной профилактики клещевого вирусного энцефалита
US20060240117A1 (en) Snake powder extract for treatment of cancer

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BV The patent application has lapsed